Aprea Therapeutics, Inc. (APRE) announced on Thursday that Nadeem Q. Mirza, who has been part of the company's senior team as a consultant since February 2023, will be taking on the role of Chief Medical Officer, effective May 1, 2024.
Mirza has over 30 years of clinical and developmental experience in solid tumors and hematologic malignancies. Before joining Aprea Therapeutics, Mirza served as Senior Vice President of Clinical Development at Salarius Pharmaceuticals.
Currently, APRE's stock is trading at $5.25, up 2.74% on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.